Exelixis (EXEL) Rated Equalweight by Barclays Amid Cancer Drug Outlook

27 9 月, 2025

One Min Read

8 Views

原文: https://finance.yahoo.com/news/exelixis-exel-rated-equalweight-barclays-045918516.html

Last Update: 27 9 月, 2025

Written By

Other Articles

Previous

Piper Sandler Sees Strong Momentum in Keurig Dr Pepper (KDP) Stock

Next

<div>SS&C Technologies (SSNC) Stock Named Top Idea by UBS Amid AI Growth</div>

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept